CORNEAL GRAFT REJECTION AFTER KERATOPLASTY
Corneal transplantation is a method of surgical treatment used to restore the optical and structural properties of the diseased cornea which is successfully performed for over 100 years. The immune rejection remains one of the most common causes of an unsatisfactory outcomes of penetrating keratopla...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2017-10-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850039771711143936 |
|---|---|
| author | S. V. Trufanov A. M. Subbot S. A. Malozhen D. A. Krakhmaleva E. P. Salovarova |
| author_facet | S. V. Trufanov A. M. Subbot S. A. Malozhen D. A. Krakhmaleva E. P. Salovarova |
| author_sort | S. V. Trufanov |
| collection | DOAJ |
| description | Corneal transplantation is a method of surgical treatment used to restore the optical and structural properties of the diseased cornea which is successfully performed for over 100 years. The immune rejection remains one of the most common causes of an unsatisfactory outcomes of penetrating keratoplasty. The cases of corneal allograft rejection range from 2.3% to 65% depending on the risk factors taking place in the recipient. The most well-known risk factors for corneal allograft rejection are neovascularization of the recipient’s cornea, active ocular inflammation, herpetic keratitis, ocular surface disease, young age, previous surgery of the anterior segment of the eye, neurotrophic keratopathy, big and eccentric graft, anterior synechia. Given the fact that the pathophysiology of corneal graft rejection is very complex and not fully understood the applied methods of treatment and prevention are often ineffective in “high risk” patients. New experimental targeted approaches including the use of antibodies and gene therapy are currently being developed but do not have a clear success in the clinic yet.Therefore for obtaining satisfactory outcomes of corneal transplantation in “high risk” patients all main known risk factors have to be taken into account with subsequent possible preoperative therapy to reduce their impact; careful monitoring of the patient in the postoperative period should be done to early detection of allograft rejection signs; optimal schemes and combinations of immunosuppressive drugs authorized for use in the clinic have to be developed. |
| format | Article |
| id | doaj-art-ae4585afeb6648eebd113440d29e1ec2 |
| institution | DOAJ |
| issn | 1816-5095 2500-0845 |
| language | Russian |
| publishDate | 2017-10-01 |
| publisher | Ophthalmology Publishing Group |
| record_format | Article |
| series | Oftalʹmologiâ |
| spelling | doaj-art-ae4585afeb6648eebd113440d29e1ec22025-08-20T02:56:15ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452017-10-0114318018710.18008/1816-5095-2017-3-180-187345CORNEAL GRAFT REJECTION AFTER KERATOPLASTYS. V. Trufanov0A. M. Subbot1S. A. Malozhen2D. A. Krakhmaleva3E. P. Salovarova4Research Institute of Eye DiseasesResearch Institute of Eye DiseasesResearch Institute of Eye DiseasesResearch Institute of Eye DiseasesResearch Institute of Eye DiseasesCorneal transplantation is a method of surgical treatment used to restore the optical and structural properties of the diseased cornea which is successfully performed for over 100 years. The immune rejection remains one of the most common causes of an unsatisfactory outcomes of penetrating keratoplasty. The cases of corneal allograft rejection range from 2.3% to 65% depending on the risk factors taking place in the recipient. The most well-known risk factors for corneal allograft rejection are neovascularization of the recipient’s cornea, active ocular inflammation, herpetic keratitis, ocular surface disease, young age, previous surgery of the anterior segment of the eye, neurotrophic keratopathy, big and eccentric graft, anterior synechia. Given the fact that the pathophysiology of corneal graft rejection is very complex and not fully understood the applied methods of treatment and prevention are often ineffective in “high risk” patients. New experimental targeted approaches including the use of antibodies and gene therapy are currently being developed but do not have a clear success in the clinic yet.Therefore for obtaining satisfactory outcomes of corneal transplantation in “high risk” patients all main known risk factors have to be taken into account with subsequent possible preoperative therapy to reduce their impact; careful monitoring of the patient in the postoperative period should be done to early detection of allograft rejection signs; optimal schemes and combinations of immunosuppressive drugs authorized for use in the clinic have to be developed.https://www.ophthalmojournal.com/opht/article/view/387corneal graft rejectionhigh risk keratoplastyimmunosuppressive therapycyclosporine atacrolimus |
| spellingShingle | S. V. Trufanov A. M. Subbot S. A. Malozhen D. A. Krakhmaleva E. P. Salovarova CORNEAL GRAFT REJECTION AFTER KERATOPLASTY Oftalʹmologiâ corneal graft rejection high risk keratoplasty immunosuppressive therapy cyclosporine a tacrolimus |
| title | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY |
| title_full | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY |
| title_fullStr | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY |
| title_full_unstemmed | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY |
| title_short | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY |
| title_sort | corneal graft rejection after keratoplasty |
| topic | corneal graft rejection high risk keratoplasty immunosuppressive therapy cyclosporine a tacrolimus |
| url | https://www.ophthalmojournal.com/opht/article/view/387 |
| work_keys_str_mv | AT svtrufanov cornealgraftrejectionafterkeratoplasty AT amsubbot cornealgraftrejectionafterkeratoplasty AT samalozhen cornealgraftrejectionafterkeratoplasty AT dakrakhmaleva cornealgraftrejectionafterkeratoplasty AT epsalovarova cornealgraftrejectionafterkeratoplasty |